Docetaxel (Hospira, Inc.)
Welcome to the PulseAid listing for the Docetaxel drug offered from Hospira, Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | DOCETAXEL |
| SUBSTANCE NAME: | DOCETAXEL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-08-24 |
| END MARKETING DATE: | 0000-00-00 |
Docetaxel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Docetaxel from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2016-08-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-0366_605fb937-7eec-4474-bb08-92f42abd19e2 |
| PRODUCT NDC: | 0409-0366 |
| APPLICATION NUMBER: | NDA022234 |
Other DOCETAXEL Pharmaceutical Manufacturers / Labelers:
